Kymera Therapeutics, Inc. Common Stock
Symbol: KYMR (NASDAQ)
46.22
▲ (6.30%) 2.740
Company Description:
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
Key Stats
- Today's Open: $44.1
- Today's High: $46.243
- Today's Low: $43.49
- Today's Volume: 632.55K
- Yesterday Close: $43.48
- Yesterday High: $43.98
- Yesterday Low: $42.705
- Yesterday Volume: 647.18K
- Last Min Volume: 432
- Last Min High: $46.22
- Last Min Low: $46.22
- Last Min VWAP: $46.22
Company Profile
- Name: Kymera Therapeutics, Inc. Common Stock
- Website: https://www.kymeratx.com
- Listed Date: 2020-08-21
- Location: WATERTOWN, MA
- Market Status: Active
- CIK Number: 0001815442
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $3.11B
- Round Lot: 100
- Outstanding Shares: 71.50M
- Asset Type: CS
RECENT FILINGS FOR KYMR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-03 | 4 | View |
| 2025-09-03 | 3 | View |
| 2025-09-03 | 8-K | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-07-17 | SCHEDULE 13G/A | View |
| 2025-07-01 | 4 | View |
| 2025-06-30 | SCHEDULE 13D/A | View |
| 2025-06-30 | 4 | View |
| 2025-06-27 | 8-K | View |
| 2025-06-27 | 8-K | View |
| 2025-06-27 | 424B5 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
Latest News on KYMR